Interferon (IFN) signaling plays a pivotal role in the efficacy of conventional cancer therapeutic strategies, attributed to its critical functions in early antigen recognition and its capacity to bridge innate sensing with the adaptive immune response [1–3]. The gene discussed is IFNA1; the disease is cancer.